ClinConnect ClinConnect Logo
Search / Trial NCT06589856

Does Oral Lactate Affect Gut Hormone Secretion in a Dose-response Relationship?

Launched by UNIVERSITY OF AARHUS · Sep 6, 2024

Trial Information

Current as of August 31, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how taking oral lactate, a substance that can be found in some foods, affects certain hormones in the gut that help control appetite and digestion. Researchers want to find out if there is a direct relationship between the amount of lactate taken and changes in gut hormones, insulin levels, and feelings of hunger. They aim to understand if taking more lactate leads to more noticeable effects on these factors.

To participate in this study, you must be between 18 and 75 years old and generally healthy. If you have certain medical conditions, are taking medications, or have specific allergies, you may not be eligible. The trial is not yet recruiting participants, but once it begins, those who join will help researchers learn more about how lactate might influence metabolism and appetite. It’s important to note that participants will be required to give their consent and should be able to understand Danish.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 18-75 years
  • Written and oral consent
  • Healthy
  • Exclusion Criteria:
  • HbA1c \> 39
  • Taking medicine
  • Any diseases
  • Allergy to paracetamol
  • Doesn't speak or understand Danish.
  • Special diets

About University Of Aarhus

The University of Aarhus, a prestigious research institution located in Denmark, is dedicated to advancing medical science through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university fosters an environment that encourages cutting-edge research and the development of novel therapeutic interventions. Committed to ethical standards and patient safety, the University of Aarhus aims to contribute to the global body of medical knowledge while enhancing healthcare outcomes through rigorous scientific inquiry and evidence-based practices.

Locations

Aarhus, Aarhus N, Denmark

Patients applied

0 patients applied

Trial Officials

Esben Sondergaard

Principal Investigator

Aarhus University, Steno Diabetes Center Aarhus

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported